Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892874106> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2892874106 endingPage "1929" @default.
- W2892874106 startingPage "1921" @default.
- W2892874106 abstract "A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease Joseph Tauber,1 Barry A Schechter,2 Jason Bacharach,3 Melissa M Toyos,4 Robert Smyth-Medina,5 Sidney L Weiss,6 Jodi I Luchs7 1Tauber Eye Center, Kansas City, MO, USA; 2Florida Eye Microsurgical Institute, Boynton Beach, FL, USA; 3North Bay Eye Associates, Petaluma, CA, USA; 4Toyos Clinic, Nashville, TN, USA; 5North Valley Eye Medical Group, Mission Hills, CA, USA; 6i-Novion, Inc, Randolph, NJ, USA; 7South Shore Eye Care, Wantagh, NY, USA Purpose: The aim of this study was to evaluate the safety and efficacy of OTX-101, a clear nanomicellar aqueous solution of cyclosporine, in the treatment of dry eye disease (DED).Patients and methods: This was a 12-week multicenter, randomized, prospective, double-masked, vehicle-controlled, dose-ranging clinical trial. Subjects were adults aged ≥18 years, with a total conjunctival staining score of ≥3 and ≤9, and global DED symptom score ≥40 (0–100 visual analogue scale). Following a 14-day vehicle run-in, subjects were randomized in a 1:1:1 ratio to twice daily treatment with OTX-101 0.09%, OTX-101 0.05%, or vehicle for 84 days. Co-primary efficacy end points were changes, from baseline to Day 84, in the total lissamine green conjunctival staining score in the designated study eye and in the global symptom score (both eyes). Secondary end points included total corneal fluorescein staining score, tear breakup time, and Schirmer’s test score.Results: In total, 455 subjects were randomized. Subjects treated with active drug experienced greater improvement in conjunctival staining than vehicle-treated patients (P" @default.
- W2892874106 created "2018-10-05" @default.
- W2892874106 creator A5009517012 @default.
- W2892874106 creator A5025291618 @default.
- W2892874106 creator A5029544057 @default.
- W2892874106 creator A5039022688 @default.
- W2892874106 creator A5054178666 @default.
- W2892874106 creator A5087354864 @default.
- W2892874106 creator A5089917783 @default.
- W2892874106 date "2018-10-01" @default.
- W2892874106 modified "2023-09-26" @default.
- W2892874106 title "A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease" @default.
- W2892874106 cites W145780728 @default.
- W2892874106 cites W1523354060 @default.
- W2892874106 cites W1986859401 @default.
- W2892874106 cites W1992063412 @default.
- W2892874106 cites W2010954738 @default.
- W2892874106 cites W2018365938 @default.
- W2892874106 cites W2028465131 @default.
- W2892874106 cites W2037727382 @default.
- W2892874106 cites W2077912787 @default.
- W2892874106 cites W2086358431 @default.
- W2892874106 cites W2088344821 @default.
- W2892874106 cites W2099738114 @default.
- W2892874106 cites W2115345791 @default.
- W2892874106 cites W2169772679 @default.
- W2892874106 cites W2318533725 @default.
- W2892874106 cites W2600375002 @default.
- W2892874106 cites W2603809109 @default.
- W2892874106 cites W2737439597 @default.
- W2892874106 cites W2737787547 @default.
- W2892874106 cites W2739359388 @default.
- W2892874106 cites W2739410682 @default.
- W2892874106 doi "https://doi.org/10.2147/opth.s175065" @default.
- W2892874106 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6174300" @default.
- W2892874106 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30323548" @default.
- W2892874106 hasPublicationYear "2018" @default.
- W2892874106 type Work @default.
- W2892874106 sameAs 2892874106 @default.
- W2892874106 citedByCount "40" @default.
- W2892874106 countsByYear W28928741062019 @default.
- W2892874106 countsByYear W28928741062020 @default.
- W2892874106 countsByYear W28928741062021 @default.
- W2892874106 countsByYear W28928741062022 @default.
- W2892874106 countsByYear W28928741062023 @default.
- W2892874106 crossrefType "journal-article" @default.
- W2892874106 hasAuthorship W2892874106A5009517012 @default.
- W2892874106 hasAuthorship W2892874106A5025291618 @default.
- W2892874106 hasAuthorship W2892874106A5029544057 @default.
- W2892874106 hasAuthorship W2892874106A5039022688 @default.
- W2892874106 hasAuthorship W2892874106A5054178666 @default.
- W2892874106 hasAuthorship W2892874106A5087354864 @default.
- W2892874106 hasAuthorship W2892874106A5089917783 @default.
- W2892874106 hasBestOaLocation W28928741061 @default.
- W2892874106 hasConcept C118487528 @default.
- W2892874106 hasConcept C141071460 @default.
- W2892874106 hasConcept C168563851 @default.
- W2892874106 hasConcept C71924100 @default.
- W2892874106 hasConceptScore W2892874106C118487528 @default.
- W2892874106 hasConceptScore W2892874106C141071460 @default.
- W2892874106 hasConceptScore W2892874106C168563851 @default.
- W2892874106 hasConceptScore W2892874106C71924100 @default.
- W2892874106 hasLocation W28928741061 @default.
- W2892874106 hasLocation W28928741062 @default.
- W2892874106 hasLocation W28928741063 @default.
- W2892874106 hasLocation W28928741064 @default.
- W2892874106 hasLocation W28928741065 @default.
- W2892874106 hasOpenAccess W2892874106 @default.
- W2892874106 hasPrimaryLocation W28928741061 @default.
- W2892874106 hasRelatedWork W1586374228 @default.
- W2892874106 hasRelatedWork W2003938723 @default.
- W2892874106 hasRelatedWork W2047967234 @default.
- W2892874106 hasRelatedWork W2089201504 @default.
- W2892874106 hasRelatedWork W2118496982 @default.
- W2892874106 hasRelatedWork W2364998975 @default.
- W2892874106 hasRelatedWork W2369162477 @default.
- W2892874106 hasRelatedWork W2439875401 @default.
- W2892874106 hasRelatedWork W4238867864 @default.
- W2892874106 hasRelatedWork W2525756941 @default.
- W2892874106 hasVolume "Volume 12" @default.
- W2892874106 isParatext "false" @default.
- W2892874106 isRetracted "false" @default.
- W2892874106 magId "2892874106" @default.
- W2892874106 workType "article" @default.